STOCK TITAN

Berry Global Group, Inc. Reports Strong Second Quarter 2021 Results; Raising Fiscal Year 2021 Earnings Guidance

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Berry Global Group, Inc. (BERY) reported second fiscal quarter 2021 results with net sales of $3.4 billion, marking a 13% increase. Operating income rose 17% to $333 million, while net income per diluted share increased 40% to $1.32. The company raised its operating EBITDA guidance for fiscal 2021 by $50 million to $2.25 billion. Organic volume growth improved to 5%. Strong demand across segments, especially health and hygiene products, contributed to positive performance amid challenges from resin price inflation.

Positive
  • Net sales increased 13% to $3.4 billion.
  • Operating income rose 17% to $333 million.
  • Net income per diluted share up 40% to $1.32.
  • Operating EBITDA guidance raised by $50 million to $2.25 billion.
  • Organic volume growth improved to 5%.
Negative
  • Negative impact from unprecedented resin price inflation expected in June 2021 quarter.
  • Increased business integration expenses by $21 million.

Berry Global Group, Inc. (NYSE:BERY), a leading supplier of sustainable packaging solutions for consumer goods and industrial products, today reported its second fiscal quarter 2021 results, referred to in the following as the March 2021 quarter.

Second Quarter Highlights

(all comparisons made to the March 2020 quarter)

  • Net sales of $3.4 billion, a 13 percent increase
  • 5 percent organic volume growth
  • Operating income up 17 percent to $333 million
  • Operating EBITDA up 9 percent to $590 million
  • Net income per diluted share up 40 percent to $1.32
  • Adjusted net income per diluted share increase of 34 percent to $1.59
  • Raising fiscal 2021 operating EBITDA guidance from prior mid-point by $50 million to $2.25 billion
  • Increasing fiscal 2021 organic volume growth assumption from 4 percent to now 5 percent

Berry’s Chairman and CEO Tom Salmon said, “The Company’s performance in our second fiscal quarter was solid as adjusted earnings per share and revenue grew by 34 percent and 13 percent, respectively, from prior year results. Consumer demand for our products remains robust and certain markets, which previously experienced COVID-19 headwinds, are rebounding nicely. All segments delivered volume growth, collectively finishing the quarter with 5 percent organic volume growth, while operating EBITDA increased 9 percent in the quarter.

“The organically driven outperformance in this second fiscal quarter gives us confidence to raise our fiscal year 2021 outlook for operating EBITDA by $50 million from the mid-point of our previous range. Our businesses, across the globe, are clearly capitalizing on our strategy to drive profitable and sustainable organic volume growth. The continued positive momentum from our investments in areas such as health and wellness, e-commerce, and food safety along with the focus on growing our emerging market exposure and driving more sustainable packaging, provide us the path to realize long-term consistent volume growth.

“We have a clear line-of-site to being within our leverage range by the end of fiscal 2021. As we stated last quarter, once within our targeted leverage range of 3.0 to 3.9 times, we believe our consistent and growing cash flow will provide substantial capacity to create shareholder value with a capital allocation approach that includes: reinvesting in the business to support continued organic growth, further debt reductions, pursuing bolt-on acquisitions, and returning capital to shareholders while staying within our committed range.”

March 2021 Quarter Results

Consolidated Overview

The net sales growth is primarily attributed to increased selling prices of $192 million due to the pass through of higher resin costs, organic volume growth of 5 percent, and a $92 million favorable impact from foreign currency changes. These increases were partially offset by prior quarter divestiture sales of $53 million. The organic volume growth was primarily due to organic growth investments, modest recovery of certain markets that had previously been facing COVID-19 headwinds, and higher demand in our advantaged health and hygiene products as the result of COVID-19.

The operating income increase is primarily attributed to a $35 million increase from the organic volume growth, a $19 million inventory step-up in the prior quarter related to the RPC acquisition, a $16 million favorable impact from price cost spread including synergies and product mix, and a $16 million favorable impact from foreign currency, partially offset by a $21 million increase in business integration expense, and a $15 million increase in selling, general, and administrative expense.

Consumer Packaging - International

The net sales growth in the Consumer Packaging International segment is primarily attributed to organic volume growth of 4 percent, and a $71 million favorable impact from foreign currency changes. The organic volume growth was primarily due to the recovery in emerging markets.

The operating income increase is primarily attributed to a $12 million favorable impact from foreign currency, an $11 million increase from the organic volume growth, and a $19 million inventory step-up in the prior quarter, partially offset by a $24 million increase in business integration activities, and an increase in depreciation and amortization.

Consumer Packaging - North America

The net sales growth in the Consumer Packaging North America segment is primarily attributed to increased selling prices of $60 million due to the pass through of higher resin costs and organic volume growth of 5 percent. The organic volume growth was primarily due to continued strength in closures, bottles, and containers

The operating income increase is primarily attributed to a $9 million increase from the organic volume growth and a decrease in depreciation and amortization, partially offset by a negative impact from price cost spread.

Health, Hygiene, & Specialties

The net sales growth in the Health, Hygiene & Specialties segment is primarily attributed to organic volume growth of 8 percent, and increased selling prices of $83 million due to the pass through of higher resin costs. The organic volume growth was primarily due to organic growth investments and higher demand in our advantaged health and hygiene products as the result of COVID-19.

The operating income increase is primarily attributed to a $12 million impact from the organic volume growth and a $31 million favorable impact from price cost spread and product mix.

Engineered Materials

The net sales growth in the Engineered Materials segment is primarily attributed to increased selling prices of $69 million due to the pass through of higher resin costs, organic volume growth of 3 percent, and a $15 million favorable impact from foreign currency changes, partially offset by prior quarter divestiture sales of $43 million.

The operating income decrease is primarily attributed to a $10 million negative impact from price cost spread and prior quarter divestiture operating income.

Cash Flow

Our cash flow from operating activities increased slightly to $323 million for the March 2021 quarter compared to $315 million in the prior year quarter. The Company’s cash flow from operating activities and free cash flow for the four quarters ended April 3, 2021, were $1,635 million and $951 million, respectively.

Balance Sheet and Liquidity

Our total debt less cash and cash equivalents at the end of the March 2021 quarter was $9,039 million. Adjusted EBITDA for the four quarters ended April 3, 2021, was $2,288 million. Our financial profile remains solid, as we have a strong liquidity position with $843 million of cash at the end of the quarter, as well as an undrawn $850 million asset-based line of credit representing nearly $1.7 billion of liquidity.

Bond Offering and Note Redemptions

In January 2021, we issued $800 million aggregate principal amount of 0.95 percent first priority senior secured notes due 2024, the proceeds from which were used to prepay a portion of our term loan debt. In February 2021, we issued an additional $775 million aggregate principal amount of our existing 1.57 percent first priority senior secured notes due 2026, the proceeds from which were used to prepay a portion of our term loan debt.

Fiscal 2021 Guidance

Given our continued strength through the first half of the year and stable demand outlook across our business, we are increasing our organic volume growth assumption for fiscal 2021 to 5 percent. This includes low single digit growth in the back half of this fiscal year, building on last year’s strong performance, and all supported by our robust and growing pipeline, increased level of capital expenditures, and the positive trends and momentum we are seeing in each of our businesses. Given the continued strength in our pipeline, we are raising our capital expenditures spending expectation by $50 million this year to support incremental growth projects. Additionally we are increasing our operating EBITDA guidance by $50 million from the mid-point of our previous guidance provided in February to now $2.25 billion. We have included a negative impact from inflation and the associated timing lag in passing through inflationary costs. We expect the majority of the impact from the recent unprecedented increases in resin prices in the United States, to impact our results in the June 2021 quarter. Though, we expect this lag will be largely offset in the June quarter from continued favorable product mix. The guidance also assumes that both of these factors dissipate in the September quarter. As a result, we expect Operating EBITDA in the back-half of the year to be split relatively evenly between the June and September quarters and will be similar with the second half prior year results when adjusted for our recent divestitures and the COVID-19 related mix benefits. We are proud of the continued strong execution by our team as the unprecedented resin inflation experienced in fiscal 2021 has been more than offset by volume growth and productivity. Free cash flow will remain in the range of $875 to $975 million. The range of free cash flow includes $1.575 to $1.675 billion of cash flow from operations, partially offset by capital expenditures of $700 million. We also continue to anticipate further strengthening our balance sheet and expect to be in our targeted range by the end of fiscal 2021.

Investor Conference Call

The Company will host a conference call today, May 4, 2021, at 10 a.m. U.S. Eastern Time to discuss our second fiscal quarter 2021 results. The telephone number to access the conference call is (800) 305-1078 (domestic), or (703) 639-1173 (international), conference ID 8789045. We expect the call to last approximately one hour. Interested parties are invited to listen to a live webcast and view the accompanying slides by visiting the Company’s Investor page at www.berryglobal.com. A replay of the conference call can also be accessed on the Investor page of the website beginning May 4, 2021, at 1 p.m. U.S. Eastern Time, to May 18, 2021, by calling (855) 859-2056 (domestic), or (404) 537-3406 (international), access code 8789046.

About Berry

At Berry Global Group, Inc. (NYSE:BERY), we create innovative packaging and engineered products that we believe make life better for people and the planet. We do this every day by leveraging our unmatched global capabilities, sustainability leadership, and deep innovation expertise to serve customers of all sizes around the world. Harnessing the strength in our diversity and industry leading talent of 47,000 global employees across more than 295 locations, we partner with customers to develop, design, and manufacture innovative products with an eye toward the circular economy. The challenges we solve and the innovations we pioneer benefit our customers at every stage of their journey. For more information, visit our website at www.berryglobal.com.

Non-GAAP Financial Measures and Estimates

This press release includes non-GAAP financial measures such as operating EBITDA, Adjusted EBITDA, Adjusted net income, and free cash flow. A reconciliation of these non-GAAP financial measures to comparable measures determined in accordance with accounting principles generally accepted in the United States of America (GAAP) is set forth at the end of this press release. Information reconciling forward-looking operating EBITDA is not provided because such information is not available without unreasonable effort due to the high variability, complexity, and low visibility with respect to certain Items, including debt refinancing activity or other non-comparable items. These items are uncertain, depend on various factors, and could be material to our results computed in accordance with U.S. GAAP. Our estimates of the impact of COVID-19 are based on product mix and prior internal sales estimates compared to actual sales.

Forward Looking Statements

Statements in this release that are not historical, including statements relating to the expected future performance of the Company, are considered “forward looking” within the meaning of the federal securities laws and are presented pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You can identify forward-looking statements because they contain words such as “believes,” “expects,” “may,” “will,” “should,” “would,” “could,” “seeks,” “approximately,” “intends,” “plans,” “projects,” “estimates,” “projects,” “outlook,” “anticipates” or “looking forward,” or similar expressions that relate to our strategy, plans, intentions, or expectations. All statements we make relating to our estimated and projected earnings, margins, costs, expenditures, cash flows, growth rates, and financial results or to our expectations regarding future industry trends are forward-looking statements. In addition, we, through our senior management, from time to time make forward-looking public statements concerning our expected future operations and performance and other developments. These forward-looking statements are subject to risks and uncertainties that may change at any time, and, therefore, our actual results may differ materially from those that we expected. We derive many of our forward-looking statements from our operating budgets and forecasts, which are based upon many detailed assumptions. While we believe that our assumptions are reasonable, we caution that it is very difficult to predict the impact of known factors, and it is impossible for us to anticipate all factors that could affect our actual results.

Important factors that could cause actual results to differ materially from our expectations, which we refer to as cautionary statements, are disclosed under “Risk Factors” and elsewhere in our Annual Report on Form 10-K and subsequent filings with the Securities and Exchange Commission, including, without limitation, in conjunction with the forward-looking statements included in this press release. All forward-looking information and subsequent written and oral forward-looking statements attributable to us, or to persons acting on our behalf, are expressly qualified in their entirety by the cautionary statements. Some of the factors that we believe could affect our results include: (1) risks associated with our substantial indebtedness and debt service; (2) changes in prices and availability of resin and other raw materials and our ability to pass on changes in raw material prices to our customers on a timely basis; (3) risks related to acquisitions or divestitures and integration of acquired businesses and their operations, and realization of anticipated cost savings and synergies; (4) risks related to international business, including as a result of the RPC transaction, including foreign currency exchange rate risk and the risks of compliance with applicable export controls, sanctions, anti-corruption laws and regulations; (5) uncertainty regarding the United Kingdom’s withdrawal from the European Union and the outcome of future arrangements between the United Kingdom and the European Union; (6) reliance on unpatented proprietary know-how and trade secrets; (7) the phase-out of the London Interbank Offered Rate (LIBOR), or the replacement of LIBOR with a different reference rate or modification of the method used to calculate LIBOR, which may adversely affect interest rates; (8) increases in the cost of compliance with laws and regulations, including environmental, safety, anti-plastic legislation, production, and product laws and regulations; (9) employee shutdowns or strikes or the failure to renew effective bargaining agreements; (10) risks related to disruptions in the overall economy and the financial markets that may adversely impact our business, including as a result of the COVID-19 pandemic; (11) risk of catastrophic loss of one of our key manufacturing facilities, natural disasters, and other unplanned business interruptions; (12) risks related to the failure of, inadequacy of, or attacks on our information technology systems and infrastructure; (13) risks related to market acceptance of our developing technologies and products; (14) general business and economic conditions, particularly an economic downturn; (15) risks that our restructuring programs may entail greater implementation costs or result in lower cost savings than anticipated; (16) ability of our insurance to fully cover potential exposures; (17) risks related to future write-offs of substantial goodwill; (18) risks of competition, including foreign competition, in our existing and future markets; (19) new legislation or new regulations and the Company’s corresponding interpretations of either may affect our business and consolidated financial condition and results of operations; (20) risks related to the impact of travel and safety restrictions related to the COVID-19 pandemic, including on our internal controls over financial reporting and the ongoing process of implementing standardized internal control procedures within the recently acquired RPC business; and (21) the other factors discussed in the section titled “Risk Factors” in our Annual Report on Form 10-K and subsequent filings with the Securities and Exchange Commission. We caution you that the foregoing list of important factors may not contain all of the material factors that are important to you. In addition, in light of these risks and uncertainties, the matters referred to in the forward-looking statements contained herein may not in fact occur. Accordingly, readers should not place undue reliance on those statements. All forward-looking statements are based upon information available to us on the date hereof. All forward-looking statements are made only as of the date hereof and we undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.

Berry Global Group, Inc.

Consolidated Statements of Income

(Unaudited)

(in millions of dollars, except per share data amounts)

 

 

 

 

 

Quarterly Period Ended

 

Two Quarterly Periods Ended

 

April 3,
2021

 

March 28,
2020

 

April 3,
2021

 

March 28,
2020

 

 

 

 

 

 

 

 

Net sales

$

3,370

 

$

2,975

 

$

6,506

 

$

5,791

Costs and expenses:

 

 

 

 

 

 

 

Cost of goods sold

 

2,706

 

 

2,391

 

 

5,224

 

 

4,687

Selling, general and administrative

 

220

 

 

204

 

 

461

 

 

433

Amortization of intangibles

 

73

 

 

77

 

 

147

 

 

152

Restructuring and transaction activities

 

38

 

 

19

 

 

37

 

 

{ "@context": "https://schema.org", "@type": "FAQPage", "name": "Berry Global Group, Inc. Reports Strong Second Quarter 2021 Results; Raising Fiscal Year 2021 Earnings Guidance FAQs", "mainEntity": [ { "@type": "Question", "name": "What were Berry Global's second quarter 2021 financial results?", "acceptedAnswer": { "@type": "Answer", "text": "Berry Global reported net sales of $3.4 billion with a 13% increase compared to the previous year, and operating income rose 17%." } }, { "@type": "Question", "name": "How did Berry Global's net income per share change in Q2 2021?", "acceptedAnswer": { "@type": "Answer", "text": "The net income per diluted share increased by 40% to $1.32 in the second quarter of 2021." } }, { "@type": "Question", "name": "What is the updated operating EBITDA guidance for Berry Global in fiscal 2021?", "acceptedAnswer": { "@type": "Answer", "text": "The operating EBITDA guidance for fiscal 2021 has been raised by $50 million to $2.25 billion." } }, { "@type": "Question", "name": "What was the organic volume growth rate reported by Berry Global for Q2 2021?", "acceptedAnswer": { "@type": "Answer", "text": "Berry Global reported an organic volume growth rate of 5% for the second quarter of 2021." } }, { "@type": "Question", "name": "What challenges is Berry Global facing due to resin prices?", "acceptedAnswer": { "@type": "Answer", "text": "Berry Global expects a negative impact from unprecedented resin price inflation primarily affecting results in the June 2021 quarter." } } ] }

FAQ

What were Berry Global's second quarter 2021 financial results?

Berry Global reported net sales of $3.4 billion with a 13% increase compared to the previous year, and operating income rose 17%.

How did Berry Global's net income per share change in Q2 2021?

The net income per diluted share increased by 40% to $1.32 in the second quarter of 2021.

What is the updated operating EBITDA guidance for Berry Global in fiscal 2021?

The operating EBITDA guidance for fiscal 2021 has been raised by $50 million to $2.25 billion.

What was the organic volume growth rate reported by Berry Global for Q2 2021?

Berry Global reported an organic volume growth rate of 5% for the second quarter of 2021.

What challenges is Berry Global facing due to resin prices?

Berry Global expects a negative impact from unprecedented resin price inflation primarily affecting results in the June 2021 quarter.

Berry Global Group, Inc.

NYSE:BERY

BERY Rankings

BERY Latest News

BERY Stock Data

8.07B
114.79M
0.22%
101.18%
3.79%
Packaging & Containers
Plastics Products, Nec
Link
United States of America
EVANSVILLE